Toggle navigation
Home
Search
Services
Blog
Contact
About
Phase 1 and Phase 2 Clinical Trials of Agents for Cancer Prevention
Search grants from
Share this grant:
:
:
Abstract
Funding
Related projects
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Mechanisms of TNF-alpha Mediated Resolution of Pulmonary Fibrosis
Uncovering Conserved Lipid Homeostasis Mechanisms that Mediate Longevity after Germ Cell Loss in C. Elegans
Mechanotransduction and calcium regulation in cochlear hair cells
A 12 Year Follow Up of A Cocaine Dependent Sample
Ultraviolet Damage Repair in Bacillus Subtilis Spore DNA
Recently added grants:
Cyclic Peptide Protease Inhibitors for the Treatment of Prostate Cancer
Maternal buprenorphine-naloxone treatment during the perinatal period: Fetal and infant effects
Program 12: Developmental Therapeutics
Program 13: Cancer Risk and Disparities
In vivo characterization of opioid biased agonists
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research and Development Contracts (N01)
Project #
N01CN35000-8-0-1
Application #
7579487
Study Section
Project Start
2003-09-30
Project End
2008-09-29
Budget Start
Budget End
Support Year
Fiscal Year
2007
Total Cost
Indirect Cost
Related projects
NIH 2008
N01 CA
Phase 1 and Phase 2 Clinical Trials of Agents for Cancer Prevention
/ Mayo Clinic, Rochester
$2,258,000
NIH 2007
N01 CA
Phase 1 and Phase 2 Clinical Trials of Cancer Chemopreventive Agents
Limburg, Paul J. /
$2,257,713
NIH 2007
N01 CA
Phase 1 and Phase 2 Clinical Trials of Agents for Cancer Prevention
/
Comments
Be the first to comment on this grant